
|
08:30-09:00 | KTA vs. ATA guidelines: Endocrinologist’s perspectives Eun Kyung Lee (National Cancer Center, Korea) |
|
09:00-09:30 | Long-term follow-up strategies in differentiated thyroid cancer: Focus on TSH suppression Yoon Young Cho (Soon Chun Hyang University, Korea) |
|
09:30-10:00 | Recent trends and clinical applications of radioactive iodine therapy in thyroid cancer Sophie Leboulleux (University of Geneva, Switzerland) |
|
13:40-14:10 | Optimizing targeted therapy for treatment of radioiodine-refractory thyroid cancer Won Gu Kim (University of Ulsan, Korea) |
|
14:10-14:40 | Immune checkpoint inhibitors and combination therapy in thyroid cancer Sun Min Lim (Yonsei University, Korea) |
|
14:40-15:10 | Immune-related adverse events: From mechanistic insights to management Yoo Hyung Kim (Seoul National University, Korea) |
|
16:10-16:40 | Thyroid cancer and the metabolic landscape: Clinical and translational perspectives Hyemi Kwon (Sungkyunkwan University, Korea) |
|
16:40-17:10 | Causal inference and modern statistical approach in thyroid epidemiology Kosuke Inoue (Kyoto University, Japan) |
|
17:10-17:40 | Molecular drivers in thyroid cancer Carmelo Nucera (Beth Israel Deaconess Medical Center, Harvard Medical School, USA) |
|
14:50-15:20 | The AI horizon in thyroidology Wonsang Yoo (Dankook University, Korea) |
|
15:20-15:50 | Updates regarding thyroid function and iodine nutrition in pregnancy Chun-Jui Huang (Taipei Veterans General Hospital, Taiwan) |
|
15:50-16:20 | Updates in ultrasonography for benign thyroid diseases: Beyond thyroid nodules Han-Sang Baek (The Catholic University of Korea, Korea) |